Voyager Therapeutics (VYGR) Long-Term Investments (2015 - 2026)

Voyager Therapeutics' Long-Term Investments history runs 12 years deep, the most recent figure standing at $30.2 million for Q1 2026.

• In Q1 2026, Long-Term Investments fell 48.93% year-over-year to $30.2 million; the TTM figure through Mar 2026 stood at $30.2 million (down 48.93% YoY), while the FY2025 annual figure was $5.2 million, down 92.02% from the prior year.
• Long-Term Investments came in at $30.2 million for Q1 2026 at Voyager Therapeutics, up from $5.2 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $65.7 million in Q4 2024 to a low of $1.0 million in Q1 2024.
• A 5-year average of $14.5 million and a median of $1.8 million in 2022 frame the typical range for Long-Term Investments.
• On a YoY basis, Long-Term Investments climbed as much as 5810.3% in 2025 and fell as far as 92.02% in 2025.
• Voyager Therapeutics' Long-Term Investments stood at $1.5 million in 2022, then grew by 5.15% to $1.6 million in 2023, then jumped by 4024.54% to $65.7 million in 2024, then sank by 92.02% to $5.2 million in 2025, then soared by 475.53% to $30.2 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $30.2 million, $5.2 million, and $20.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison